Clinical Trials Directory

Trials / Completed

CompletedNCT04002531

A One Visit Follow Up of Adults With Fabry Disease Who Started Long-term Enzyme Replacement Therapy As Children

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
5 (actual)
Sponsor
Baylor Research Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to obtain follow up data on a cohort of well-studied patients with Fabry disease who have been on ERT since childhood for a total of about 15 years.

Detailed description

The long-term effect of initiating ERT in childhood is unknown. Prospective studies of Children with Fabry disease on 0.2 mg/kg agalsidase alfa every other week were performed. The patients were 7-17 years of age at initial study enrollment. The first open-label protocol was TKT023, a 6 months study (August 12, 2002-October 20, 2004) that was followed by an extension study TKT029 (June 10, 2004-June 15, 2011; ClinicalTrials.gov identifier NCT00084084). Since completing TKT029, all US patients were switched to commercial agalsidase beta. Therefore, these patients have now been treated for about 15 years.This study involves a one-visit follow up on these patients using the same protocol-driven studies as were used in TKT029. The long-term follow up data gathered will consist of a rare description of the disease profile in patients who were treated with ERT since childhood.

Conditions

Interventions

TypeNameDescription
OTHERGeneral and Neurological examinationInformation about your general health, neurological symptoms and current medications with be collected
OTHERVital signsHeight, weight, blood pressure, heart rate, and respiratory rate and temperature will be measured.
PROCEDURE12 lead electrocardiogramA non-invasive test that measures the electrical activity of the heart
PROCEDUREEchocardiogramA non-invasive sonogram of the heart
PROCEDUREBlood drawBlood will be drawn to evaluate general health and renal function (kidney health)
PROCEDUREUrine collectionUrine will be collection to evaluate renal function (kidney health)
PROCEDURE2-hour Holter MonitorA non-invasive test that measures the electrical activity of the heart continuously over 2 hours
OTHERBrief Pain Inventory questionnaireA questionnaire about daily pain
OTHERQuality of Life questionnaireA questionnaire about the impact of disease on their activities of daily living and quality of life

Timeline

Start date
2018-11-10
Primary completion
2019-12-13
Completion
2019-12-13
First posted
2019-06-28
Last updated
2026-03-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04002531. Inclusion in this directory is not an endorsement.